Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

The book provides an overview of new trends and techniques in cosmetic dermatology.

The document emphasizes early detection and treatment of men's skin conditions and recommends protective measures and appropriate treatments for different age groups.

The document concludes that accurate diagnosis and understanding the type of hair disorder are crucial for treating hair loss in children.

Telocytes might help with skin repair and regeneration.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Scalp melanomas are more dangerous and often missed, needing earlier detection.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

People with Seasonal Affective Disorder have different brain activity in certain areas when resting.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Dermabrasion improves skin appearance by removing the top layer to promote healing.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

The conclusion suggests a new way to classify bradykinin-mediated angio-oedema based on different causes and its possible link with urticaria, which could improve diagnosis and treatment.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Most HIV-positive patients had skin problems, and conditions like oral thrush and boils were linked to weaker immune systems.

Syphilis can cause hair loss without other symptoms and should be considered when diagnosing unexplained hair loss.

The we/we wal/wal mice have defects in hair growth and skin layer formation, causing hair loss, useful for understanding alopecia.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

High proliferative activity and peripheral invasion indicate malignancy in canine sebaceous gland tumors; the term 'epithelioma' should be updated for clarity.

Netherton Syndrome can cause severe skin lesions in rare cases.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Some people have a genetic variation that makes them less effective at breaking down drugs.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.